e-learning
resources
Munich 2006
Sunday 03.09.2006
Lung cancer, haemoptoe, smoking and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effective use of corticosteroids in the treatment of plastic bronchitis with hemoptysis in Chinese adults: a nine-year clinical experience
G. Wang, J. Y. Wang, M. F. Luo, L. Wang, L. L. Jiang (Chengdu, China)
Source:
Annual Congress 2006 - Lung cancer, haemoptoe, smoking and COPD
Session:
Lung cancer, haemoptoe, smoking and COPD
Session type:
E-Posters in free access
Number:
362
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Wang, J. Y. Wang, M. F. Luo, L. Wang, L. L. Jiang (Chengdu, China). Effective use of corticosteroids in the treatment of plastic bronchitis with hemoptysis in Chinese adults: a nine-year clinical experience. Eur Respir J 2006; 28: Suppl. 50, 362
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Antibiotics use for asthma exacerbation in Japanese geriatric patients
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
The use of omalizumab in the management of severe chronic paediatric asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008
Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002
Use of long acting bronchodilators and inhaled corticosteroids within 30-days of discharge in older adults hospitalized for AECOPD
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Managing pediatric pneumonia by following guidelines to decrease the use of concurrent asthma medication.
Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others
Year: 2019
Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
New treatments in severe paediatric asthma
Source: International Congress 2017 – PG7 Paediatric asthma
Year: 2017
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Asthma in pre-schoolers: difficult to treat
Source: Annual Congress 2005 - Asthma in the preschool child
Year: 2005
Impact of COVID-19 side-effects on pediatric and adult patients with recurrent wheeze and asthma
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021
Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Prevalence of oral corticosteroid use in the German severe asthma population
Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019
Year: 2019
Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Predictors of adherence to inhaled corticosteroids in children with asthma and their parents in a multi-ethnic population
Source: Annual Congress 2007 - Education, communication and quality of life in childhood asthma
Year: 2007
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
Source: ERJ Open Res, 8 (1) 00014-2022; 10.1183/23120541.00014-2022
Year: 2022
Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia
Source: Eur Respir J 2011; 37: 36-41
Year: 2011
Long-term management of persistent asthma in adults
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=376
Year: 2003
Combination asthma medication and healthcare use in severe or difficult-to-treat asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004
Long-term inhaled corticosteroid use in COPD and the risk of fracture in men and women
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Is nebulized morphine effective in treating persistent dyspnea in very severe COPD? A preliminary report
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept